Asymptomatic carotid artery stenosis and the risk of new vascular events in patients with manifest arterial disease: The SMART study
Goessens BM et al. (2007) Asymptomatic carotid artery stenosis and the risk of new vascular events in patients with manifest arterial disease: The SMART study. Stroke 38: 1470-1475
Long-term risk of stroke and other vascular events in patients with asymptomatic carotid artery stenosis
Nadareishvili ZG et al. (2002) Long-term risk of stroke and other vascular events in patients with asymptomatic carotid artery stenosis. Arch Neurol 59: 1162-1166
Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis
Rothwell PM et al. (2003) Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 361: 107-116
Chambers BR and Donnan GA. Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD001923.pub2. doi:10.1002/14651858.CD001923.pub2
Chambers BR and Donnan GA. Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD001923.pub2. doi:10.1002/14651858.CD001923.pub2
5
0028938324
Endarterectomy for asymptomatic carotid artery stenosis
Executive Committee for the Asymptomatic Carotid Atherosclerosis Study
Executive Committee for the Asymptomatic Carotid Atherosclerosis Study (1995) Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273: 1421-1428
Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial
Halliday A et al. (2004) Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial. Lancet 363 1491-502
Atorvastatin treatment in patients with carotid stenosis is associated with a marked reduction in the risk of stroke, cardiovascular events and carotid revascularisation procedures: A substudy of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial
Sillesen H et al. (2007) Atorvastatin treatment in patients with carotid stenosis is associated with a marked reduction in the risk of stroke, cardiovascular events and carotid revascularisation procedures: a substudy of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Cerebrovasc Dis 23 (Suppl 2) 55
Carotid endarterectomy - an evidence-based review: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Chaturvedi S et al. (2005) Carotid endarterectomy - an evidence-based review: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 65: 794-801